Given that KRASG12D PDAC‐derived CD109+EVs deliver circPNIT to neurons and trigger axonogenesis‐induced PNI, we sought to determine the targeted engagement of circPNIT in the primary tumor tissue generated by KRASG12D PDAC. Here, CD109 is linked to neoplasm.